Offices of Technology Transfer
Welcome to the web site for the Offices of Technology Transfer. We are the teams who facilitate the protection of Intellectual Property and the commercialization—or transfer—of technologies resulting from the cutting-edge research being conducted by our world-class scientists, faculty, and staff here at the University of Rochester and the University of Rochester Medical Center.
We are here to translate scientific innovation into tangible products or methods that advance knowledge and serve the public good while returning income to the inventor and to the University to support further research.
November 2009: Featured Technology
Forebrain Glial Restricted Precursor Cells for Cell Transplantation Therapy of Brain/ Spinal Injuries and Diseases
This invention provides the first clearly characterized glial restricted precursor cell (GRP) isolated from forebrain that can be used for trans-plantation in injury and disease models. Forebrain glial precursor cell can be used as a source generating GDA like cells and a tool for drug screen.
The invention develops glial restricted precursor cells originated from forebrain. The cells possess unique properties that distinguish them from any other glial precursor cells described to date. The utilization of the cells will solve a number of potential problems associated with the use of glial restricted precursor cells isolated from the spinal cord.
Inventors:
Margot Mayer-Proschel, Ph.D.
Frederick Strathmann, Ph.D.
For More Information, Contact:
Michael Rusnak
Associate Director for Biological Sciences
585.784.8850
Stay Informed
Subscribe to the Technology Transfer RSS feed, and be notified when new topics are added to our Technology listings.
